Given their effectiveness and expanding range of benefits, it is no wonder that GLP-1 receptor agonists are becoming an increasingly popular choice for both doctors and patients alike
For most patients, doctors consider several key factors when determining eligibility: Body mass index (BMI): Typically recommended for those with a BMI over 30, or over 27 if weight-related conditions such as diabetes, hypertension, or sleep apnea are present
Diabetes coverage for Ozempic and Mounjaro is rarely carved out because diabetes is a near-universal benefit on commercial plans
Always consult your healthcare provider regarding your specific health needs
preclinical data suggests that this accumulation activates the hypoxia-inducible factor 2-alpha (HIF-2) pathway to induce chondrocyte hypertrophic differentiation, which may contribute to OA progression (59)
Regular check-ins throughout your treatment cycle allow for protocol adjustments that optimize your outcomes and help you work through side effect challenges rather than abandoning therapy prematurely